SCOPUS
Future Rare Diseases
Taylor & Francis, United Kingdom
Future Rare Diseases is an academic journal published by Taylor & Francis (United Kingdom). Identifiers: eISSN 2399-5270. Indexed in SCOPUS. Metrics: CiteScore 1.2, SJR 0.250, SNIP 0.23. tlooto lists 174 papers from this journal.
CiteScore
1.20
Scopus citation metric
SJR
0.250
SCImago rank
SNIP
0.23
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2399-5270
- Abbreviation
- -
- Publisher
- Taylor & Francis
- Country
- United Kingdom
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2700 General Medicine
Papers in this journal
Recent papers
- Plain language summary: A real-world analysis of long-term treatment with eliglustat in people with Gaucher disease type 1
2026
- A plain language summary of oral berotralstat for preventive treatment of hereditary angioedema attacks in children: early safety and efficacy results of the ongoing APeX-P study
2026
- How I treat Rett syndrome: impact of trofinetide on symptoms and comorbidities of the disease
2026
- The design of AIRTIVITY – a research study of verducatib as a potential new type of treatment for bronchiectasis: a plain language summary
2026
- Dupilumab for the treatment of prurigo nodularis
2026
Most cited papers
- Research and development of oligonucleotide therapeutics in Japan for rare diseases
2022 · 26 citations
- The global role of patients, advocates and caregivers in rare diseases
2022 · 15 citations
- Nefecon (targeted-release formulation-budesonide) for the treatment of IgA nephropathy
2021 · 13 citations
- GALILEO-1: a Phase I/II safety and efficacy study of FLT201 gene therapy for Gaucher disease type 1
2023 · 8 citations
- Living with lung fibrosis: knowledge is power
2023 · 6 citations